Xiangyu Medical Co.,Ltd (688626.SS)
CNY 34.06
(-4.06%)
CNY 34.06
(-4.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 244.62 Million CNY | 82.64% |
| 2022 | 135.46 Million CNY | -39.54% |
| 2021 | 224.05 Million CNY | 0.32% |
| 2020 | 223.35 Million CNY | 51.78% |
| 2019 | 147.15 Million CNY | 56.67% |
| 2018 | 93.92 Million CNY | 21.14% |
| 2017 | 77.53 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 18.59 Million CNY | 162.29% |
| 2024 Q1 | 42.2 Million CNY | -57.96% |
| 2024 Q2 | 7.09 Million CNY | -83.2% |
| 2023 Q3 | 74.14 Million CNY | 6.3% |
| 2023 FY | 247.41 Million CNY | 82.64% |
| 2023 Q4 | 100.4 Million CNY | 35.41% |
| 2023 Q2 | 69.75 Million CNY | 57.98% |
| 2023 Q1 | 44.15 Million CNY | 29.09% |
| 2022 Q3 | 55.07 Million CNY | 53.38% |
| 2022 Q2 | 35.91 Million CNY | 249.78% |
| 2022 Q1 | 10.26 Million CNY | -86.87% |
| 2022 FY | 135.46 Million CNY | -39.54% |
| 2022 Q4 | 34.2 Million CNY | -37.9% |
| 2021 Q4 | 78.19 Million CNY | 62.32% |
| 2021 Q1 | 39.17 Million CNY | -56.97% |
| 2021 FY | 224.05 Million CNY | 0.32% |
| 2021 Q3 | 48.17 Million CNY | -17.66% |
| 2021 Q2 | 58.5 Million CNY | 49.36% |
| 2020 Q1 | 24.02 Million CNY | -44.66% |
| 2020 Q4 | 91.03 Million CNY | 108.48% |
| 2020 Q3 | 43.66 Million CNY | -32.43% |
| 2020 Q2 | 64.62 Million CNY | 169.0% |
| 2020 FY | 223.35 Million CNY | 51.78% |
| 2019 FY | 147.15 Million CNY | 56.67% |
| 2019 Q4 | 43.41 Million CNY | 0.0% |
| 2018 FY | 93.92 Million CNY | 21.14% |
| 2017 FY | 77.53 Million CNY | 0.0% |